Atorvastatin and gemfibrozil for protease-inhibitor-related lipid abnormalities

被引：163

作者：

Henry, K ^{[1
]}

Melroe, H

Huebesch, J

Hermundson, J

Simpson, J

机构：

[1] Reg Hosp, Lipid Program, HIV AIDS Program, St Paul, MN 55101 USA

[2] Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA

来源：

LANCET | 1998年 / 352卷 / 9133期

关键词：

D O I：

10.1016/S0140-6736(98)00022-1

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

收藏

页码：1031 / 1032

页数：2

相关论文

共 5 条

[1] A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors
Carr, A
Samaras, K
Burton, S
Law, M
Freund, J
Chisholm, DJ
Cooper, DA
[J]. AIDS, 1998, 12 (07) : F51 - F58
[2] Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance
Carr, A
Samaras, K
Chisholm, DJ
Cooper, DA
[J]. LANCET, 1998, 351 (9119) : 1881 - 1883
[3] Chronic infections and coronary heart disease: is there a link?
Danesh, J
Collins, R
Peto, R
[J]. LANCET, 1997, 350 (9075) : 430 - 436
[4] Severe premature coronary artery disease with protease inhibitors
Henry, K
Melroe, H
Huebsch, J
Hermundson, J
Levine, C
Swensen, L
Daley, J
[J]. LANCET, 1998, 351 (9112) : 1328 - 1328
[5] Prediction of myocardial infarction in dyslipidemic men by elevated levels of immunoglobulin classes A, E, and G, but not M
Kovanen, PT
Mänttäri, M
Palosuo, T
Manninen, V
Aho, K
[J]. ARCHIVES OF INTERNAL MEDICINE, 1998, 158 (13) : 1434 - 1439